HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 3,133-3,144 of 4,505
Other study type icon
CompletedNCT01512290

Theta-Burst Brain Stimulation for Persistent Voices in Psychosis

About this title

Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations

Read the official source — NCT01512290
Official study title

Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations; a Placebo-controlled Trail

This study has finished and is no longer accepting participants.

In Utrecht
SchizophreniaPlacebo comparisonAges 18+
Countries
Netherlands
Sponsor
UMC Utrecht
Behavioral study icon
CompletedNCT05577338

ToM Psychotherapy and Brain Networks in EOS

Official study title

Neural Mechanism Underlying the Beneficial Effect of Theory of Mind Psychotherapy on Early-onset Schizophrenia: A Randomized Controlled Trial.

This study has finished and is no longer accepting participants.

In Hefei
SchizophreniaBehavioural studyAges 13–18
Countries
China
Sponsor
The First Affiliated Hospital of Anhui Medical University
Device study icon
CompletedNCT03483909

Transcranial Magnetic Stimulation to Improve Gesture Control

Official study title

Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Gesture Control in Schizophrenia: A Randomised, Placebo-controlled, Double-blind Crossover Trial

This study has finished and is no longer accepting participants.

In Bern
SchizophreniaDevice studyAges 18–65
Countries
Switzerland
Sponsor
University of Bern
Device study icon
TerminatedNCT02242578

Treating Refractory Schizophrenia With rTMS

Official study title

Effect of rTMS Over the Medial Cerebellum on Negative Symptoms and Cognitive Dysmetria in Subjects With Treatment Refractory Schizophrenia

This study ended early.

In Austin
SchizophreniaDevice studyAges 18–80
Countries
United States
Sponsor
Seton Healthcare Family
Drug study icon
CompletedNCT00043849

Quetiapine for agitation or psychosis in dementia and Parkinson’s disease

About this title

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Read the official source — NCT00043849
Official study title

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
SchizophreniaMedication studyAges 50+
Countries
United States
Sponsor
National Institute on Aging (NIA)
Device study icon
CompletedNCT02451371

Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia

Official study title

A Pilot Study for the Treatment of Refractory Auditory Verbal Hallucinations With Transcranial Direct Current Stimulation(tDCS) in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Seoul
SchizophreniaDevice studyAges 19–50
Countries
South Korea
Sponsor
Seoul National University Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.